loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 20645 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SODIUM BENZOATE; SODIUM PHENYLACETATE (1)

filter

01 BAUSCH (1)

filter

01 SOLUTION;INTRAVENOUS (1)

filter

01 10%;10% (5GM/50ML;5GM/50ML) (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION;INTRAVENOUS
10%;10% (5GM/50ML;5GM/...
AMMONUL
USA
20645
2005-02-17
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 20645

Looking for CTD TGA MCC DOSSIER APPLICATION 20645 1

19

Bausch & Lomb Incorporated, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is SODIUM BENZOATE; SODIUM PHENYLACETATE, with a corresponding application number 20645 and regulatory information .

proudly manufactured in the

approval since 2005-02-17

Bausch & Lomb Incorporated's AMMONUL SOLUTION;INTRAVENOUS, medication with 10%;10% (5GM/50ML;5GM/50ML) of SODIUM BENZOATE; SODIUM PHENYLACETATE.

Post Enquiry
POST ENQUIRY